数字化认知行为疗法联合同伴支持用于镰状细胞病青少年和年轻成人慢性疼痛:PRESENCE平行三臂随机对照试验研究方案
PRESENCE试验招募470名16-30岁伴慢性疼痛的镰状细胞病(SCD)青少年和年轻成人(AYA),按3:3:2随机分配至数字化认知行为疗法(CBT)联合同伴支持组、单纯CBT组或常规照护组。主要目的是比较任何数字化CBT组与常规照护组在随机化后6个月时疼痛强度和疼痛干扰的降低程度,次要目的是比较CBT联合同伴支持组与单纯CBT组的差异。
要点
- 数字化CBT联合或不联合同伴支持,旨在改善SCD青少年和年轻成人慢性疼痛结局。
- 主要结局为随机化后6个月疼痛强度和疼痛干扰较基线的变化。
- 同伴支持由经过培训、具有亲身经历者每周提供,以提升数字化CBT参与度。
核心结论
- PRESENCE试验将评估数字化CBT联合同伴支持对SCD青少年和年轻成人慢性疼痛的疗效,并为优化数字化干预提供证据。
研究设计与样本
- 多中心、平行三臂随机对照试验,计划招募470名16-30岁伴慢性疼痛的SCD青少年和年轻成人。
- 参与者按3:3:2随机分配至CBT联合同伴支持组、单纯CBT组或常规照护组。
- 评估在基线、随机化后3、6和12个月完成,干预和数据收集通过研究移动应用程序进行。
关键数值与推荐
- 主要目的:确定接受任何数字化CBT的AYA在随机化后6个月时疼痛强度和疼痛干扰的降低是否大于常规照护组。
- 次要目的:确定CBT联合同伴支持在随机化后6个月降低疼痛强度和疼痛干扰方面是否优于单纯CBT。
- 次要结局包括日均疼痛强度、疼痛天数、每周平均阿片类药物剂量、急诊就诊、医疗利用、内化污名、抑郁和焦虑症状及SCD自我效能的变化。
临床怎么用
- 若证实有效,数字化CBT联合同伴支持可能为SCD青少年和年轻成人提供可扩展、可及且文化适应的疼痛管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sickle cell disease (SCD) affects millions globally, with pain being the most prevalent symptom. Adolescents and young adults (AYAs) with SCD face high rates of pain crises and healthcare encounters. Digital cognitive behavioral therapy (CBT) shows promise for pain management but faces engagement challenges. The PRESENCE study aims to enhance engagement in and benefit from digital CBT for SCD by adding personalized peer support. METHODS: This multisite, randomized controlled trial is recruiting 470 AYAs (ages 16-30) with SCD who report chronic pain. Participants are randomized 3:3:2 respectively to one of three groups: (1) CBT with peer support (CBT + Peer), (2) CBT alone (CBT), or (3) usual care (UC). Participants are provided access to the study mobile application, which is used for intervention delivery and data collection. Peer support is provided weekly by trained peer coaches who are individuals with lived experience. Evaluations are completed at baseline, 3, 6, and 12 months post randomization. The primary study aim is to determine whether AYAs receiving any digital CBT have greater reductions in pain intensity and pain interference at 6 months post randomization compared to those receiving UC. The secondary aim is to determine whether CBT + Peer is superior to CBT in reducing pain intensity and interference at 6 months. Secondary outcomes include reductions in mean daily pain intensity, pain days, average weekly opioid dose, emergency department visits, healthcare utilization, internalized stigma, and depression and anxiety symptoms, and improvements in sickle cell self-efficacy. DISCUSSION: Findings from the PRESENCE trial will inform patients, parents, and providers on how digital CBT and peer support will improve pain management. Ultimately, this study will advance our understanding of how digital interventions can be optimized for populations with complex chronic conditions like SCD, where stigma and healthcare navigation can be barriers to effective care delivery. This approach could offer a scalable, accessible, and culturally responsive strategy to improve pain outcomes, reduce opioid reliance, and enhance overall health and well-being for AYAs with SCD. TRIAL REGISTRATION: Clinicaltrials.gov NCT06374238. Registered on April 2025.
引用
- O'Brien JA, Colvin AB, Radovic A, et al. Digital cognitive behavioral therapy and peer support for adolescents and young adults with sickle cell disease and chronic pain: study protocol of a parallel, three-arm, randomized controlled trial (PRESENCE). Trials. 2026. PMID: 42121176. doi:10.1186/s13063-025-08963-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。